reports
InvestmentPitch Media Video Discusses THC BioMed’s Launch of State-of-...
InvestmentPitch Media Video Discusses THC BioMed’s Launch of State-of-the-Art Medical Dispensary in Thailand VANCOUVER, British Columbia, June 22, 2023 (GLOBE NEWSWIRE) -- THC BioMed Intl (CSE:THC) (OTCQB:THCBF) (FSE:TFHD), one of Canada’s oldest licensed producers of medical and recreational cannabis, has launched a state-of-the-art medical dispensary in Thailand. For more information, please view the InvestmentPitch Media video which provides additional information about this news and the company. The video is available for viewing on “” and on “”. If these links are not enabled, p...
InvestmentPitch Media Video Discusses THC BioMed’s Launch of Sales and...
InvestmentPitch Media Video Discusses THC BioMed’s Launch of Sales and Exports of its Patented “Clone Shipper” Product to Asia VANCOUVER, British Columbia, March 02, 2023 (GLOBE NEWSWIRE) -- THC BioMed Intl (CSE:THC) (OTCQB:THCBF) (FSE:TFHD), one of Canada’s oldest licensed producers of medical and recreational cannabis, has started sales and export of its patented Clone Shipper containers to Asia. The innovative Clone Shipper container’s patented design enables plants, especially clones or young plants, to be shipped safely while nurturing the plant in the growing process. For more ...
InvestmentPitch Media Video Discusses THC BioMed’s Granting of a Licen...
InvestmentPitch Media Video Discusses THC BioMed’s Granting of a License by an Overseas Government to Cultivate Cannabis for Medical and Scientific Use – Video Available on Investmentpitch.com VANCOUVER, British Columbia, Jan. 28, 2022 (GLOBE NEWSWIRE) -- THC BioMed Intl (CSE:THC) (OTCQX:THCBF) (FSE:TFHD), one of Canada’s oldest licensed producers of medical and recreational cannabis, has been granted a license by an overseas government to cultivate cannabis for medical and scientific use. With its cultivation and production based in Kelowna, B.C., including a proprietary extraction syste...
A director sold 1,297,000 shares at 0.688CAD and
A director at Thc Biomed Intl Ltd sold 1,297,000 shares at 0.688CAD and the significance rating of the trade was 66/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two yea...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.